CLINICAL-MODELS OF CHEMOPREVENTION FOR THE ESOPHAGUS

Authors
Citation
Dg. Beer et Gd. Stoner, CLINICAL-MODELS OF CHEMOPREVENTION FOR THE ESOPHAGUS, Hematology/oncology clinics of North America, 12(5), 1998, pp. 1055
Citations number
110
Categorie Soggetti
Oncology,Hematology
ISSN journal
08898588
Volume
12
Issue
5
Year of publication
1998
Database
ISI
SICI code
0889-8588(1998)12:5<1055:COCFTE>2.0.ZU;2-X
Abstract
The two principal types of esophageal cancer are (1) adenocarcinoma, d erived from Barrett's metaplasia, and (2) squamous cell carcinoma, whi ch arises from epithelial dysplasia. Adenocarcinoma occurs frequently in the United States and rarely in the Middle East and Far East, where as the opposite is true for esophageal squamous cell carcinoma. Both c ancers have a poor prognosis. Chemoprevention is likely to be a viable approach to reduce the incidence of and mortality from these diseases . Approaches for the chemoprevention of esophageal adenocarcinoma and squamous cell carcinoma are presented in this article, and events asso ciated with both the initiation and promotion/progression stages of th ese diseases are addressed. The results of completed trials for the ch emoprevention of these cancers are summarized, and suggestions are mad e for future trials involving additional strategies and endpoints.